Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Underperformer
425.9500 -16.00 (-3.62%)
NSE Jan 16, 2026 15:54 PM
Volume: 534.9K
 

logo
Cohance Lifesciences Ltd.
25 Mar 2025
425.95
-3.62%
Suven Pharma Gets 'Buy' On ICICI Securities Initiation, Sees 19% Upside
Suven Pharma Gets 'Buy' On ICICI Securities Initiation, Sees 19% Upside
NDTV Profit
ICICI Securities initiates coverage on Suven Pharma with a Buy rating and a target price of Rs 1,400 (upside of ~19%).
Promoters have decreased holdings from 66.41% to 57.49% in Sep 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended
Market closes higher, buoyed by a rally in IT stocks
Trendlyne Marketwatch | 16 Jan 2026, 04:20PM
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline | 15 Jan 2026, 01:13PM
The top five: Analysts pick their winners for Q3
The Baseline | 15 Jan 2026, 11:06AM